Quick Answer
Arcadia Biosciences, Inc. reported Net Income of -$2.34 million for fiscal year 2025.
Arcadia Biosciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$2.34M | +66.8% |
| 2024 | -$7.04M | +49.7% |
| 2023 | -$13.98M | +9.1% |
| 2022 | -$15.38M | -4.9% |
| 2021 | -$14.66M | -214.9% |
| 2020 | -$4.66M | +83.8% |
| 2019 | -$28.80M | -113.7% |
| 2018 | -$13.48M | +14.2% |
| 2017 | -$15.71M | +20.0% |
| 2016 | -$19.62M | -9.3% |
| 2015 | -$17.96M | +2.1% |
| 2014 | -$18.34M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $856.0K | +153.1% | +119.2% |
| June 30, 2025 | -$4.46M | -520.2% | -271.5% |
| March 31, 2025 | $2.60M | +207.3% | +261.2% |
| September 30, 2024 | -$1.61M | +37.2% | -251.9% |
| June 30, 2024 | $1.06M | +28.9% | +143.8% |
| March 31, 2024 | -$2.42M | +74.2% | +5.6% |
| September 30, 2023 | -$2.57M | +10.5% | -411.9% |
| June 30, 2023 | $823.0K | +121.8% | +108.8% |
- Arcadia Biosciences, Inc. showed an increase of +66.8% in Net Income compared to the prior fiscal year.
- Over the 2014–2025 period, Arcadia Biosciences, Inc.’s net income has grown by 87.2% (from -$18.34 million to -$2.34 million).
- The most recent figure is from Arcadia Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: